Increased IL-1α expression is correlated with bladder cancer malignant progression
Shi-Jie Yao1, Hong-Shun Ma1, Guang-Ming Liu1
1Department of Urology, Tianjin First Central Hospital, Tianjin, China.
Archives of Medical Science : AMS
|February 23, 2023
Summary
Interleukin 1α (IL-1α) is highly expressed in bladder cancer (BCa) and linked to poorer survival. Reducing IL-1α inhibits cancer cell proliferation and invasion, suggesting it's a potential BCa therapy target.
Area of Science:
- Oncology
- Immunology
Background:
- Bladder cancer (BCa) remains a significant health concern.
- Understanding the role of specific molecular markers is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the functional role of interleukin 1α (IL-1α) in bladder cancer (BCa).
- To assess IL-1α as a potential therapeutic target for BCa.
Main Methods:
- Immunohistochemistry (IHC) for IL-1α protein expression in BCa tissues.
- Kaplan-Meier analysis for survival data.
- RT-q-PCR and Western blot for gene and protein expression.
- In vitro assays (colony formation, MTT, scratch, transwell) for proliferation and invasion.
- In vivo xenograft studies.
Main Results:
- IL-1α was found to be highly expressed in BCa tissues.
- High IL-1α expression correlated significantly with shorter overall and progression-free survival.
- Knockdown of IL-1α suppressed cancer cell proliferation and invasion both in vitro and in vivo.
Conclusions:
- IL-1α plays a significant role in BCa progression.
- IL-1α inhibition demonstrates potential for therapeutic intervention in BCa.
- IL-1α is a promising candidate as a therapeutic target for BCa.
